Human Anti centriole and centrosome antibody IgG ELISA kit |
E01A0698-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Human Anti centriole and centrosome antibody IgG in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human IgG antibody Laboratories manufactures the av2345s0 midsci reagents distributed by Genprice. The Av2345S0 Midsci reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Midsci Inc.. Other Av2345S0 products are available in stock. Specificity: Av2345S0 Category: Midsci
Human true insulin,TI ELISA Kit |
SunredBio |
96 tests |
EUR 528 |
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
Human true insulin,TI ELISA Kit |
ChemNorm |
96T |
EUR 567.6 |
Chemicals information
AV320801 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
K3762905 |
ABM |
3 x 1.0 ug |
EUR 451.2 |
AV320801 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1) |
K3762906 |
ABM |
1.0 ug DNA |
EUR 200.4 |
AV320801 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
K3762907 |
ABM |
1.0 ug DNA |
EUR 200.4 |
AV320801 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
K3762908 |
ABM |
1.0 ug DNA |
EUR 200.4 |
AV-412 tosylate |
B2052-25 |
Biovision |
each |
EUR 705.6 |
Tivozanib (AV-951) |
A2251-10 |
ApexBio |
10 mg |
EUR 177.6 |
Description: Tivozanib is an inhibitor of tyrosine kinase with IC50 value of 160 pmol/L against VEGFR-2 [1].Tivozanib is a quinoline-urea derivative. As a 2nd generation TKI, it has picomolar potency against VEGFR-1, -2 and -3, and minimal c-kit inhibition. |
Tivozanib (AV-951) |
A2251-100 |
ApexBio |
100 mg |
EUR 477.6 |
Description: Tivozanib is an inhibitor of tyrosine kinase with IC50 value of 160 pmol/L against VEGFR-2 [1].Tivozanib is a quinoline-urea derivative. As a 2nd generation TKI, it has picomolar potency against VEGFR-1, -2 and -3, and minimal c-kit inhibition. |
Tivozanib (AV-951) |
A2251-25 |
ApexBio |
25 mg |
EUR 226.8 |
Description: Tivozanib is an inhibitor of tyrosine kinase with IC50 value of 160 pmol/L against VEGFR-2 [1].Tivozanib is a quinoline-urea derivative. As a 2nd generation TKI, it has picomolar potency against VEGFR-1, -2 and -3, and minimal c-kit inhibition. |
Tivozanib (AV-951) |
A2251-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 189.6 |
Description: Tivozanib is an inhibitor of tyrosine kinase with IC50 value of 160 pmol/L against VEGFR-2 [1].Tivozanib is a quinoline-urea derivative. As a 2nd generation TKI, it has picomolar potency against VEGFR-1, -2 and -3, and minimal c-kit inhibition. |
Cytochrome P450 2A6V2 Antibody |
abx149665-100ug |
Abbexa |
100 ug |
EUR 526.8 |
|
Cytochrome P450 2A6V2 Antibody |
DF4754 |
Affbiotech |
200ul |
EUR 420 |
Cytochrome P450 2A6V2 Blocking Peptide |
DF4754-BP |
Affbiotech |
1mg |
EUR 234 |
Putative Olfactory Receptor 5AV1 (OR5AV1) Antibody |
20-abx217541 |
Abbexa |
|
|
|